The effects of extended-release injectable naltrexone and incentives for opiate abstinence in heroin-dependent adults in a model therapeutic workplace: A randomized trial
- 1 April 2019
- journal article
- research article
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 197, 220-227
Abstract
No abstract availableKeywords
Funding Information
- National Institute on Drug Abuse of the National Institutes of Health (R01DA019497, T32DA07209)
This publication has 34 references indexed in Scilit:
- Employment-based reinforcement of adherence to an FDA approved extended release formulation of naltrexone in opioid-dependent adults: A randomized controlled trialDrug and Alcohol Dependence, 2012
- Employment‐based reinforcement of adherence to depot naltrexone in unemployed opioid‐dependent adults: a randomized controlled trialAddiction, 2011
- Methadone maintenance therapy versus no opioid replacement therapy for opioid dependenceCochrane Database of Systematic Reviews, 2009
- A Randomized, Controlled Trial of Financial Incentives for Smoking CessationNew England Journal of Medicine, 2009
- Psychosocial interventions and opioid detoxification for drug misuse: summary of NICE guidanceBMJ, 2007
- Contingency management for treatment of substance use disorders: a meta‐analysisAddiction, 2006
- A Web-Based Therapeutic Workplace for the Treatment of Drug Addiction and Chronic UnemploymentBehavior Modification, 2005
- Evaluation of a behavioral measure of risk taking: The Balloon Analogue Risk Task (BART).Journal of Experimental Psychology: Applied, 2002
- Evaluation of a behavioral measure of risk taking: The Balloon Analogue Risk Task (BART).Journal of Experimental Psychology: Applied, 2002
- Comparing assessments of DSM-IV substance dependence disorders using CIDI-SAM and SCANDrug and Alcohol Dependence, 1996